COMP <GO>
BFRI vs OPTH // RSI-14 & 200D SMA MOMENTUM
Biofrontera Inc. (NASDAQ) VS. Optimi Health Corp. (NASDAQ) • 15-METRIC TALLY: BFRI 1
— OPTH 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: BFRI
LAST: $0.87 (-0.32%) • MKT CAP: $13.0M
rsi-technicals
43.5
LAST: $2.24 (-7.05%) • MKT CAP: $13.8M
rsi-technicals
23.6
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BFRI VS. OPTH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BFRI | OPTH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -27.20% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -25.30% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 11.70% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 43.5 | 23.6 | +19.90 | BFRI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.0M | $13.8M | -$834.7K | OPTH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BFRI REV | OPTH REV | BFRI GROSS % | OPTH GROSS % | BFRI FCF | OPTH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $41.7M | — | — | — | -$13.4M | — |
| FY 2024 | $37.3M | — | — | — | -$10.3M | — |
| FY 2023 | $34.1M | — | — | — | -$24.9M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BFRI // BETA —
OPTH // BETA —